Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (110)	4/17/1998 5:17:00 PM
From: Vector1	Read Replies (3) \| Respond to of 4974

Symbol(s) 4738 & Date Use Page Up, Page Down, +, -, or press U -------------------------------------------------------------------------------- 04/17 5:14P (DJ) Biotechnology Grp Has 5.5% Aquila Biopharma Stake >AQLA Story 4738 (AQLA, I/DRG, N/DJN, N/DJWI, N/TNM, M/NCY, P/DPH, R/MA, R/NME...) WASHINGTON (Dow Jones)--A group including Biotechnology Value Fund L.P. has a 5.5% investment stake in Aquila Biopharmaceuticals Inc. (AQLA). In a filing Friday with the Securities and Exchange Commission, the group said it holds 320,984 common shares of the Worcester, Mass., company for investment purposes. (END) DOW JONES NEWS 04-17-98 05:14 PM Additional Codes (R/US, R/USE)